These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2014975)

  • 1. In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
    Fuchs PC; Stickel S; Anderson PH; Barry AL; Shilling S
    Antimicrob Agents Chemother; 1991 Jan; 35(1):182-4. PubMed ID: 2014975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inactivation of aminoglycosides by apalcillin.
    Wright DN; Hale DC; Saxon B; Matsen JM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):353-4. PubMed ID: 3717936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin.
    Pickering LK; Rutherford I
    J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatis.
    Segreti J; Kapell KS; Trenholme GM
    Diagn Microbiol Infect Dis; 1992; 15(4):371-3. PubMed ID: 1611854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
    Giamarellou H
    Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1991 Feb; 44(2):130-9. PubMed ID: 2041154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides.
    Riff LJ; Thomason JL
    J Antibiot (Tokyo); 1982 Jul; 35(7):850-7. PubMed ID: 7174538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S; Hanaki H; Nagayama A
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.
    Walterspiel JN; Feldman S; Van R; Ravis WR
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1875-8. PubMed ID: 1952861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics.
    Glew RH; Pavuk RA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):474-7. PubMed ID: 6651276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin.
    Pickering LK; Gearhart P
    Antimicrob Agents Chemother; 1979 Apr; 15(4):592-6. PubMed ID: 464591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. I. Effect of sulbactam against beta-lactams resistant strains and in vitro combined effect of sulbactam/cefoperazone with each of piperacillin, latamoxef, ceftazidime, fosfomycin and doxycycline].
    Kouda M; Kumagai I; Kobayashi J; Sugai R; Matsuzaki H
    Jpn J Antibiot; 1990 Apr; 43(4):636-58. PubMed ID: 2199689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of time and temperature on inactivation of aminoglycosides by ampicillin at neonatal dosages.
    Daly JS; Dodge RA; Glew RH; Keroack MA; Bednarek FJ; Whalen M
    J Perinatol; 1997; 17(1):42-5. PubMed ID: 9069064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the ability of four aminoglycoside assay techniques to detect the inactivation of aminoglycosides by beta-lactam antibiotics.
    Pfaller MA; Granich GG; Valdes R; Murray PR
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):93-100. PubMed ID: 6370573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli.
    Kuo HY; Wang FD; Yen YF; Lin ML; Liu CY
    New Microbiol; 2009 Jan; 32(1):49-55. PubMed ID: 19382669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative in vitro activity of ampicillin, cefoperazone, their combinations with sulbactam and other antibiotics with respect to staphylococci and pneumococci].
    Sidorenko SV; Rezvan SP; Speranskaia ON; Tikhonova As; Navashin SM; Ansolis LE; Tsvigun EA; Kuleshov SE; Budanov SV
    Antibiot Khimioter; 1995 Mar; 40(3):22-7. PubMed ID: 7575010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefoperazone-sulbactam: Singapore experience.
    Kumarasinghe G; Chow C; Chiu C; Cheong YM
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):734-7. PubMed ID: 9253876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S; Marre R
    Infection; 1991; 19(2):106-9. PubMed ID: 1646771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.